title: Mirtazapine as an alternative for selective-serotonin-reuptake-inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone.
authors.forename: Taichi
authors.initials: T
authors.lastname: Mogi
authors.forename: Aihide
authors.initials: A
authors.lastname: Yoshino
authors.forename: Gaku
authors.initials: G
authors.lastname: Ikemoto
authors.forename: Soichiro
authors.initials: S
authors.lastname: Nomura
mesh_terms: D000368:Aged; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D003863:Depression / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008803:Mianserin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D020280:Sertraline / Q000009:adverse effects*
chemical_list: D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D000078785:Mirtazapine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline